Zacks Investment ResearchWed, 17 Jun 2026 22:50:31 GMTAmgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to KnowAMGN-1.19%
Zacks Investment ResearchWed, 17 Jun 2026 14:50:21 GMTWhy Amgen (AMGN) is a Top Momentum Stock for the Long-TermAMGN-1.19%
CNBCSat, 13 Jun 2026 12:00:01 GMTDrugmakers race to find a place in the next wave of obesity drugsAMGN-1.19%
Zacks Investment ResearchWed, 10 Jun 2026 22:50:25 GMTAmgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to NoteAMGN-1.19%
Zacks Investment ResearchWed, 10 Jun 2026 13:32:21 GMTCan Amgen's MariTide Win Share in the Fast-Growing Obesity Market?AMGN-1.19%
Seeking AlphaTue, 09 Jun 2026 16:52:11 GMTAmgen Inc. (AMGN) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptAMGN-1.19%
MarketBeatTue, 09 Jun 2026 15:07:00 GMTAmgen Eyes 2026 ‘Springboard' as Growth Drugs Offset Patent PressureAMGN-1.19%
Zacks Investment ResearchMon, 08 Jun 2026 14:01:27 GMTAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should KnowAMGN-1.19%
The Motley FoolFri, 05 Jun 2026 23:00:00 GMTAmgen: A Biotech Giant's Path to Recovery and GrowthAMGN-1.19%
MarketBeatFri, 05 Jun 2026 05:03:24 GMTAmgen Touts MariTide, AI Gains and 2026 Growth Plans at Jefferies ConferenceAMGN-1.19%
Seeking AlphaThu, 04 Jun 2026 16:51:57 GMTAmgen Inc. (AMGN) Presents at Jefferies Global Healthcare Conference 2026 TranscriptAMGN-1.19%
Zacks Investment ResearchTue, 02 Jun 2026 16:15:16 GMTAmgen Secures EU Nod for Imdylltra in Lung Cancer IndicationAMGN-1.19%
Zacks Investment ResearchMon, 01 Jun 2026 14:51:12 GMTHere's Why Amgen (AMGN) is a Strong Momentum StockAMGN-1.19%
Zacks Investment ResearchWed, 27 May 2026 15:37:32 GMTNovo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy?AMGN-1.19%
Zacks Investment ResearchTue, 26 May 2026 14:25:58 GMTAMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits?AMGN-1.19%
Zacks Investment ResearchTue, 26 May 2026 14:01:24 GMTAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should KnowAMGN-1.19%
WSJThu, 21 May 2026 10:24:00 GMTDoctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deathsAMGN-1.19%
WSJFri, 15 May 2026 19:37:00 GMTTwenty people in Japan who took an Amgen rare immune-disease drug have died, according to the company that sells the medicine in Japan. U.S. drug regulators had asked Amgen to voluntarily withdraw the drug.AMGN-1.19%
